Free Trial
→ I was wrong about Trump (From Porter & Company) (Ad) Free IPHYF Stock Alerts

Innate Pharma (IPHYF) SEC Filings & 10K Form

Innate Pharma logo
$1.31 0.00 (0.00%)
As of 07/14/2025
Compare

Recent Innate Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
07/07/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:05 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
7:31 AM		Innate Pharma (Subject)
Innate Pharma SA (Subject)
NOVO NORDISK A S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
5:11 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2025
5:17 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/19/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
10:31 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
8:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/29/2025
5:48 PM		Innate Pharma (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SCHEDULE 13G/A
04/29/2025
2:02 PM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
7:28 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
5:05 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
5:07 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
6:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
6:07 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
6:23 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2025
6:24 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
5:16 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
6:57 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
7:16 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2025
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
6:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
5:04 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
5:02 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
5:01 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
5:00 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)

Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.

For the moment, you can watch this interview free of charge – just click here.
10/29/2024
6:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:11 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:15 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:03 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2024
5:15 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2024
5:07 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
3:00 PM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/09/2024
5:13 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
5:10 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
5:11 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
5:06 AM		Innate Pharma (Filer)
Innate Pharma SA (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:IPHYF) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored